RNF168 and endothelial dysfunction: With this approach, we revealed translational regulation of SND1 as a key mediator of sunitinib-induced endothelial dysfunction, which suggests that targeting SND1 translation and the SND1 downstream factors UBE2N, RNF8, and RNF168 is a potential therapeutic strategy for vascular dysfunction.